Published Year: 2023
Interventional Imaging Market - A Global and Regional Analysis: Focus on Offering, Application, End
The global interventional imaging market is projected to reach $16.93 billion by 2033 from...
Market Research Report
A quick peek into the report
Global Interventional Ultrasound Market Industry Overview
Introduction of Interventional Ultrasound Market
The global interventional ultrasound market, initially valued at $2,238.7 million in 2024, is projected to witness substantial growth, surging to $4,223.7 million by 2035, marking a remarkable compound annual growth rate (CAGR) of 6.05% over the period from 2025 to 2035.
This steady growth is being driven by the increasing preference for minimally invasive procedures, a rising global burden of chronic diseases, and the expanding use of image-guided interventions across clinical specialties such as cardiology and oncology. Interventional ultrasound offers several advantages over traditional modalities, including real-time guidance, reduced radiation exposure, and cost-effectiveness, making it increasingly attractive for both hospital and outpatient settings.
Technological innovations, such as the incorporation of contrast-enhanced ultrasound, elastography, and artificial intelligence-based automation, are further enhancing the precision, usability, and diagnostic value of interventional ultrasound systems. However, limitations such as operator dependency, variability in image quality, and reimbursement challenges in certain regions may constrain market penetration. Despite these barriers, ongoing R&D efforts, increasing clinical applications, and growing demand for real-time, non-radiative imaging are expected to support the sustained expansion of the interventional ultrasound market.
Market Introduction
The interventional ultrasound market has been undergoing significant transformation, driven by continuous technological advancements, strategic partnerships, and expanding clinical applications that emphasize minimally invasive, real-time image-guided interventions. Companies are increasingly integrating artificial intelligence, 3D imaging, elastography, and contrast-enhanced ultrasound into their platforms to enhance procedural accuracy and workflow efficiency. Innovations such as GE HealthCare’s Versana Premier, Canon Inc.’s Aplio i-series, and Siemens Healthineers AG’s AI-enabled interventional ultrasound systems reflect this trend. Strategic acquisitions and R&D investments are further broadening product portfolios and reinforcing market presence. As ultrasound-guided biopsies, tumor ablation, and vascular access procedures become more widely adopted, interventional ultrasound is increasingly positioned as a cornerstone of modern image-guided therapeutics, offering precision, safety, and radiation-free alternatives across diverse clinical settings.
Industrial Impact
The global interventional ultrasound market has been experiencing a notable shift in clinical practice, driven by growing demand for real-time, radiation-free imaging solutions across a wide range of therapeutic procedures. Industry leaders such as Canon Inc., Esaote SPA, GE HealthCare, Koninklijke Philips N.V., and Siemens Healthineers AG have been playing a central role in advancing interventional ultrasound technologies that support precision-guided interventions beyond traditional diagnostic applications. These systems are critical tools in oncology, cardiology, and emergency medicine, enabling targeted treatments with minimal patient trauma. By streamlining complex procedures, reducing reliance on fluoroscopy or CT, and enhancing access in outpatient and resource-limited settings, interventional ultrasound has been contributing to more efficient care delivery and improved procedural outcomes. The market’s industrial impact is further amplified by its role in broadening clinical capabilities and supporting the global trend toward minimally invasive, value-based healthcare.
Market Segmentation:
Segmentation 1: by Application
• General Surgery
• Cancer
• Cardiac and Endovascular
• Others
General Surgery Segment to Dominate the Interventional Ultrasound Market (by Application)
Based on application, the global interventional ultrasound market was led by general surgery, which held a 39.8% share in 2024. The segment dominates the market primarily due to its broad clinical utility and increasing adoption of minimally invasive surgical systems. Interventional ultrasound is increasingly being used in general surgical procedures for real-time guidance in biopsies, fluid drainage, tumor ablation, and vascular access. Its ability to provide dynamic, real-time imaging without radiation exposure makes it an ideal modality for intraoperative decision-making and precision targeting.
Segmentation 2: by End User
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others (Research Use)
Hospitals and Clinics Segment to Dominate the Interventional Ultrasound Market (by End User)
Based on end user, the global interventional ultrasound market was led by the hospitals and clinics segment, which held a 79.1% share in 2024. Hospitals and clinics dominate the interventional ultrasound market based on end-users due to the pivotal role hospitals and large clinical centers play in delivering advanced, high-volume, and multidisciplinary interventional care. Equipped with state-of-the-art infrastructure, skilled healthcare professionals, and dedicated departments such as general surgery, oncology, cardiology, and emergency medicine, hospitals are ideally positioned to adopt and utilize interventional ultrasound systems for a wide range of procedures. These systems are essential for enabling precise, real-time guidance during minimally invasive interventions, ultimately improving procedural outcomes and reducing patient recovery times. The capacity of hospitals and clinics to invest in next-generation technologies, including AI-integrated and portable ultrasound platforms, further supports their leadership in this segment. Moreover, the increasing shift toward outpatient and day-care procedures within clinical settings continues to reinforce their market share, making hospitals and clinics the cornerstone of interventional ultrasound adoption globally.
Segmentation 3: by Region
• North America
o U.S.
o Canada
• Europe
o U.K.
o France
o Germany
o Italy
o Spain
o Rest-of-Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest-of-Asia-Pacific
• Latin America
o Brazil
o Mexico
o Rest-of-Latin America
• Middle East and Africa
The interventional ultrasound market in the Asia-Pacific region is expected to witness a significant growth rate of 7.06% during the forecast period. This strong growth trajectory is driven by a combination of factors, including rapid advancements in healthcare infrastructure, rising demand for minimally invasive procedures, and the increasing adoption of real-time imaging technologies across surgical and diagnostic settings. Asia-Pacific is home to some of the most technologically advanced hospitals and academic institutions, particularly in countries such as China, Japan, South Korea, and India, where there is growing investment in precision medicine and image-guided therapies. Additionally, the region's large patient population and increasing prevalence of chronic conditions such as cancer, cardiovascular disease, and liver disorders have been fueling the demand for interventional ultrasound across a variety of specialties.
Recent Developments in the Interventional Ultrasound Market
• In February 2024, Canon Inc. introduced the Aplio beyond, a compact, eco-friendly ultrasound system that integrates advanced imaging capabilities with ergonomic design, aiming to enhance clinical workflows and patient care.
• In January 2025, GE HealthCare has received FDA 510(k) clearance for its updated Voluson Expert Series ultrasound systems, including the Voluson Expert 22, 20, and 18, which integrate advanced artificial intelligence features, enhanced imaging tools, and ergonomic design to improve workflow efficiency and diagnostic accuracy in women’s healthcare, particularly for high-risk pregnancies.
• In August 2024, Koninklijke Philips N.V. partnered with Carilion Clinic to equip the new Cardiovascular Institute at Crystal Spring Tower with 11 advanced interventional suites, integrating cutting-edge imaging and ultrasound technologies to enhance cardiovascular care and optimize clinical performance for complex procedures.
• In April 2024, Esaote Group established a new manufacturing facility in Uttar Pradesh, India, through its subsidiary Esaote Asia-Pacific Diagnostic Private Limited, to produce advanced Made in India ultrasound systems for the local market. The site is expected to deliver the MyLab A, MyLab E series, and compact portable models, all featuring AI-powered augmented insight technology and innovative touchscreen controls.
Demand – Drivers, Challenges, and Opportunities
Market Drivers
Rising Demand for Minimally Invasive Procedures: The increasing demand for minimally invasive procedures is a key driver of the interventional ultrasound market. Minimally invasive techniques have been transforming the healthcare landscape by offering clear advantages over traditional open surgeries, including a lower risk of infection and significantly faster recovery times. According to Paragon Surgical Center, patients undergoing minimally invasive treatments can typically resume normal activities within days or weeks, compared to the extended recovery periods associated with open surgeries. Interventional ultrasound plays a central role in this transformation by providing real-time, radiation-free imaging that allows for precise targeting during procedures such as biopsies, tumor ablations, and vascular access. This not only minimizes collateral tissue damage but also enhances procedural accuracy and safety. Further, as the global burden of chronic conditions rises and patient preferences shift toward quicker and less invasive treatments, the adoption of interventional ultrasound systems is expected to accelerate across diverse clinical settings.
Market Challenges
High Cost of Equipment and Procedures: Despite its clinical benefits, the high cost associated with advanced interventional ultrasound systems remains a significant barrier to broader adoption, particularly in cost-sensitive and resource-limited environments. High-end ultrasound platforms equipped with AI-driven software and contrast-enhanced imaging features demand substantial capital investment, making them less accessible to smaller clinics or public healthcare institutions. Moreover, procedure-related expenses, including disposable instruments and ongoing maintenance, can further strain healthcare budgets. These cost constraints limit deployment in rural and underserved regions, where access to advanced imaging is already restricted. Addressing these affordability challenges is expected to be crucial to achieving more equitable adoption of interventional ultrasound technology worldwide.
Market Opportunities
Expansion in Emerging Markets: Emerging markets present a substantial growth opportunity for the interventional ultrasound market, driven by rising healthcare investments, improving infrastructure, and increasing awareness of minimally invasive techniques. Countries in Asia-Pacific, Latin America, and the Middle East have been witnessing rapid growth in healthcare expenditure and a growing burden of chronic diseases, creating demand for scalable and cost-effective imaging solutions. Additionally, initiatives by governments and global health organizations to improve access to diagnostic and therapeutic tools are accelerating the adoption of interventional ultrasound systems. Market players expanding their presence through local partnerships, training programs, and region-specific product lines stand to benefit significantly from the untapped potential in these fast-growing economies.
Analyst’s Thoughts
According to Swati Sood, Principal Analyst – BIS Research, “The interventional ultrasound market is poised for steady growth, fueled by the global shift toward minimally invasive procedures, increasing adoption of real-time imaging technologies, and the rising burden of chronic conditions. As healthcare providers seek safer, faster, and more cost-effective alternatives to traditional surgeries, interventional ultrasound has been emerging as a critical enabler of precision-guided care. The integration of AI, portable platforms, and expanded clinical applications is expected to continue to shape the market’s trajectory, offering compelling opportunities for technological advancement and geographic expansion.”
Interventional Ultrasound Market - A Global and Regional Analysis
Focus on Application, End User, and Region - Analysis and Forecast, 2025-2035
Some Faq's
Frequently Asked Questions
An interventional ultrasound system is a specialized medical imaging technology designed to guide and assist in minimally invasive procedures using real-time ultrasound imaging. Unlike diagnostic ultrasound, which is primarily used for observing internal body structures, interventional ultrasound is actively used during procedures to improve precision, safety, and outcomes.
To strengthen their position in the interventional ultrasound market, companies have been focusing on the development and launch of advanced systems that incorporate technologies such as artificial intelligence and contrast-enhanced ultrasound to improve procedural accuracy and efficiency. Market players are also expanding into emerging regions by tailoring cost-effective and portable ultrasound solutions to meet local demands. Continuous product innovation remains a core strategy, with companies launching next-generation platforms featuring improved imaging, workflow automation, and real-time interventional guidance. Additionally, acquisitions and investments in clinician training programs have been supporting the wider adoption of these technologies, further consolidating leadership positions in the evolving interventional ultrasound landscape.
The following are the USPs of this report:
• Market regulations and key trends in the interventional ultrasound market
• Market dynamic analysis of the opportunities, trends, and challenges in the market
The interventional ultrasound market report is valuable for a variety of stakeholders. Medical device manufacturers and suppliers can utilize it to understand market trends, growth opportunities, and competitive strategies, thereby enhancing their product offerings. Healthcare providers, including hospitals, academic medical centers, and surgical clinics, will find it useful for evaluating the benefits of integrating advanced interventional ultrasound systems into their practices, ensuring improved patient outcomes and operational efficiency.
Similar Product
You may also like
Published Year: 2021
Global Next Generation Ultrasound Systems Market: Focus on Product Type, Technology, and Application
The global next-generation ultrasound systems market was valued at $8,246.8 million in 2020...